China Isotope and Radiation Corporation

China Isotope and Radiation Corporation
Name	China Isotope and Radiation Corporation
Type	State-owned enterprise
Industry	Nuclear technology
Founded	1965
Headquarters	Beijing, People's Republic of China
Products	Radioisotopes, radiopharmaceuticals, industrial radiography sources, sealed sources
Owner	State-owned

China Isotope and Radiation Corporation is a state-owned enterprise in the People's Republic of China specializing in isotope production, radiation sources, and radiopharmaceuticals. The corporation operates within the nuclear infrastructure of China and interacts with national institutions and international organizations in atomic energy, medical imaging, and industrial applications. Its activities intersect with major Chinese agencies, research institutes, and manufacturing centers.

History

Founded amid mid-20th century expansion of nuclear capabilities, the company developed alongside institutions such as the China National Nuclear Corporation, China Atomic Energy Authority, Institute of High Energy Physics, and provincial centers in Lanzhou and Guangzhou. Early projects connected to programs coordinated by the Ministry of Industry and Information Technology and municipal authorities like the Beijing Municipal Commission of Economy and Information Technology. The corporation's timeline includes collaboration with entities such as the China Academy of Engineering Physics, Tsinghua University, Peking University, and the Chinese Academy of Sciences for isotope separation, target processing, and radiochemical techniques. During modernization phases it aligned with industrial groups including China North Industries Group and China National Nuclear Power Group to expand production of sealed sources and radiopharmaceuticals. International milestones involved interactions with the International Atomic Energy Agency, exchanges with the European Organization for Nuclear Research, and procurement relationships referencing standards from organizations like the International Commission on Radiological Protection.

Organization and Structure

The corporation's governance interfaces with state councils and oversight bodies such as the State-owned Assets Supervision and Administration Commission and regulatory authorities including the National Nuclear Safety Administration. Operational divisions coordinate with academic partners like the Shanghai Jiao Tong University, Zhejiang University, Fudan University, and technical institutes such as the China Institute of Atomic Energy and the Harbin Institute of Technology. Manufacturing and distribution networks span sites near industrial clusters in Tianjin, Shenzhen, Chengdu, and Xi'an, working with logistics partners including municipal customs offices at ports like Shanghai Port and Qingdao Port. The company maintains research symbiosis with hospitals and medical centers such as the Peking Union Medical College Hospital, Ruijin Hospital, West China Hospital, and nuclear medicine departments across provincial centers.

Products and Services

Products encompass medical radioisotopes like Technetium-99m generators, Iodine-131 therapeutic isotopes, and diagnostic tracers used in single-photon emission computed tomography and positron emission tomography cycles; industrial offerings include sealed sources for industrial radiography, irradiation services for sterilization used by pharmaceutical firms and food processors, and calibration standards for radiation monitoring equipment. The corporation supplies materials compatible with equipment made by vendors such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and services used by institutes like the China National Medical Products Administration-regulated hospitals. It also manufactures sources for scientific instruments used at facilities like the Shanghai Synchrotron Radiation Facility and supports isotope applications in agriculture at research stations such as Chinese Academy of Agricultural Sciences centers.

Research and Development

R&D programs partner with universities and national laboratories including the National Center for Nanoscience and Technology, Institute of Physics (CAS), and the National University of Defense Technology to advance radiochemistry, cyclotron targetry, and radiopharmaceutical formulation. Projects have interfaced with international research hubs such as the European Molecular Biology Laboratory, the Lawrence Berkeley National Laboratory, and collaborations tied to accelerator technology at the Paul Scherrer Institute. Clinical trials and translational research involve hospitals like Tongji Hospital and regulatory review by agencies like the National Health Commission. Technology transfer and patents sometimes engage corporate partners such as China National Pharmaceutical Group and device makers like Canon Medical Systems.

Safety, Regulation, and Environmental Impact

Safety frameworks reference guidelines from the International Atomic Energy Agency, standards by the International Organization for Standardization, and national legislation administered by the National Nuclear Safety Administration and the Ministry of Ecology and Environment. Compliance activities interface with emergency response units including municipal civil defense bureaus in cities like Beijing, Shanghai, and Guangzhou, and occupational safety authorities such as the State Administration of Work Safety. Environmental monitoring coordinates with provincial ecology bureaus and research centers including the Chinese Research Academy of Environmental Sciences. Waste management and decommissioning practices connect to facilities operated by entities such as the China National Nuclear Corporation and technology suppliers like AREVA-related contractors and domestic engineering firms.

International Collaboration and Exports

The corporation engages in export and cooperation under frameworks involving the International Atomic Energy Agency, bilateral agreements with countries represented by missions to Beijing, and trade arrangements managed through the Ministry of Commerce and export control bodies such as the Ministry of Foreign Affairs. International partners have included institutions in Europe, Asia, Africa, and Latin America and commercial clients working with organisations like the World Health Organization for isotope supply chains. Collaborative projects have touched multinational consortia associated with the Global Harmonization Initiative and procurement aligned with international standards enforced by bodies like the Nuclear Suppliers Group and customs procedures at ports including Nanhai Port and Dalian Port.

Category:Companies of the People's Republic of China Category:Nuclear technology companies